Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis

• Published in: European journal of neurology Vol. 31; no. 10; pp. e16387 - n/a
• Main Authors: Ingvarsson, Jens, Grut, Viktor, Biström, Martin, Berg, Linn Persson, Stridh, Pernilla, Huang, Jesse, Hillert, Jan, Alfredsson, Lars, Kockum, Ingrid, Olsson, Tomas, Waterboer, Tim, Nilsson, Staffan, Sundström, Peter
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.10.2024; John Wiley and Sons Inc
• Subjects: Autoimmune diseases; Central nervous system; Clinical Medicine; Cytomegalovirus; Demyelinating diseases; Demyelination; Environmental factors; Epitopes; Epstein-Barr virus; Health risks; Herpes simplex; Herpes viruses; Klinisk medicin; Mimicry; Multiple Sclerosis; Original; Risk factors; Rubella; Statistical analysis; Vaccination; Varicella; Viruses; Vitamin D

Background Multiple sclerosis (MS) is a demyelinating disease affecting millions of people worldwide. Hereditary susceptibility and environmental factors contribute to disease risk. Infection with Epstein–Barr virus (EBV) and human herpesvirus 6A (HHV‐6A) have previously been associated with MS risk...